New data show that use of CAPHOSOL® (http://www.caphosol.com/), an advanced oral electrolyte solution, resulted in both favorable impact on rates and severity of oral mucositis (OM) in cancer patients undergoing chemotherapy and radiation therapy.

Read the rest of this entry »

ORLANDO, FL (UroToday.com) - Dr. Abraham Morgentaler and colleagues examined the relationship between testosterone (T) levels and PSA in hypogonadal men.184 patients with symptomatic hypogonadism (T <300 ng/dL) and PSA of ≤4.0 ng/mL were included in the study. All patients underwent a prostate biopsy prior to initiation of androgen supplementation therapy.

Read the rest of this entry »

ORLANDO, FL (UroToday.com) - The authors explored patterns of recurrence, muscle invasion, and disease specific mortality in patients with bladder carcinoma in situ (CIS) who responded to an induction course with intravesical BCG immunotherapy.

Read the rest of this entry »

It has been reported that the incidence of testicular cancer has plateaued in some parts of the USA, especially among non-Hispanic Whites in Los Angeles. Temporal trends analysis was conducted over three decades to assess the evidence for such a plateau, and to examine whether the incidence of testicular cancer remains stable across racial/ethnic groups. This study also investigated the influence of age at diagnosis on the incidence of testicular cancer.

Read the rest of this entry »

ORLANDO, FL (UroToday.com) - Dr. Paul Lange presented the Ramon Guiteras lecture. Surgeon-scientists have made great contributions to medicine. However, we might be one generation from ignorance and two from obsolescence, he said.

Read the rest of this entry »

A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, are more likely to live longer when taking the chemotherapy pill Xeloda (capecitabine), compared to those receiving 5-FU/FA intravenous (IV) chemotherapy. Read the rest of this entry »

Amgen (NASDAQ: AMGN) announced updated results from the “STEPP” (Skin Toxicity Evaluation Protocol with Panitumumab) trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer (mCRC) patients receiving epidermal growth factor receptor (EGFr) therapy.

Read the rest of this entry »

I’m an avid watcher of hospital shows, from ER (back in the George Clooney days) to Scrubs and Grey’s Anatomy today. So I was intrigued to check out last night’s premiere of Hopkins, a six-part ABC News series on real-life doctors and patients at Johns Hopkins Hospital.

Read the rest of this entry »

June 27, 2008 — A 23-minute video shown in the waiting rooms of various sexually transmitted disease (STD) clinics was effective in reducing the incidence of STDs, according to the results of a controlled trial published in the June 24 Open Access issue of PLoS Medicine.

Read the rest of this entry »

UNITED NATIONS (Reuters) - Researchers have been undercounting new cases of HIV infection in the United States, meaning the rate is probably 25 percent higher at 50,000 people per year, the nation’s top AIDS doctor said on Tuesday.Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said the rate of infection was not increasing but that new methods of calculating the rate showed infections were more common than previous estimates.

Read the rest of this entry »